The Bio Report

563 Episoder

1. Looking for a Better Alternative to Chemotherapy for AL Amyloidosis

   Udgivet: 15.2.2018
2. A University Spin-Out that Incubates University Spin Outs

   Udgivet: 8.2.2018
3. Understanding the Challenges and Opportunities of Patient-Centric Outcomes

   Udgivet: 2.2.2018
4. How CellMax Hopes to Change the Diagnosis Cancer with Inexpensive Liquid Biopsy

   Udgivet: 25.1.2018
5. How Surveillance and Data Are Bringing Precision to the Treatment of Prostate Cancer

   Udgivet: 18.1.2018
6. Why Life Sciences M&A Should Heat up This Year

   Udgivet: 11.1.2018
7. The Outlook for Biotech in 2018

   Udgivet: 4.1.2018
8. The Year in Biotech and What to Watch in 2018

   Udgivet: 28.12.2017
9. The Year in Immuno-Oncology and What to Watch in 2018

   Udgivet: 21.12.2017
10. What the Approval of the First Digital Pill Means for the Future of Healthcare

    Udgivet: 14.12.2017
11. Why Public Health Systems Need to Be Better Prepared for Extreme Weather Events

    Udgivet: 7.12.2017
12. Former CDC Director Takes on World’s Leading Cause of Death

    Udgivet: 30.11.2017
13. How a Public-Private Consortium Is Revolutionizing Cancer Drug Discovery

    Udgivet: 23.11.2017
14. How Faulty Thinking Can Derail Life Sciences M&A Deals

    Udgivet: 16.11.2017
15. Targeting Drug-Resistant Bacteria with an Ancient Enemy

    Udgivet: 9.11.2017
16. A Bioelectronic Approach to Treating Autoimmune Diseases

    Udgivet: 2.11.2017
17. Harnessing Patient Data to Improve Drug Development Efficiency

    Udgivet: 26.10.2017
18. How Colorifix Is Trying to Turn the Textile Industry Green

    Udgivet: 19.10.2017
19. Targeting Patients as Sick as Dogs

    Udgivet: 12.10.2017
20. A Strategic Investor’s View of the Biotech Investment Landscape

    Udgivet: 5.10.2017